Searching for escape-resistant anti–SARS-CoV-2 neutralizing antibodies

A major goal of SARS-CoV-2 vaccination is the induction of neutralizing antibodies (nAbs) capable of blocking infection by preventing interaction of the SARS-CoV-2 Spike protein with ACE2 on target cells. Cocktails of monoclonal nAbs can reduce the risk of severe disease if administered early in inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahla, Ranjeet Singh, Dustin, Lynn B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843738/
https://www.ncbi.nlm.nih.gov/pubmed/35072657
http://dx.doi.org/10.1172/JCI157416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843738/
https://www.ncbi.nlm.nih.gov/pubmed/35072657
http://dx.doi.org/10.1172/JCI157416

Ejemplares similares